Toggle navigation
Main content start

What's Happening Events

< Back to all upcoming events
17
May 2025
(Sat)

Transitioning from Traditional Diagnosis to Precision Medicine: Technologies in Medical Laboratories

Event of
CLST Open House: 智護生命:現代科技與健康管理
Subject
Medical Sciences
Print

Thanks for your participation!

The above event has been completed successfully. Please look forward to the upcoming events.

Want to read more about the event recap?

Date & time
17May 2025 (Sat)10:00 - 11:00
Type of Event
Hybrid (In-person & Online Attendance)
Venue
🔷【In-person】: Room 204, 2/F, Admiralty Centre, 18 Harcourt Road, Admiralty, HK
Online Platform
🔷【Online】: HKU SPACE YouTube Channel
Fee
Free
Speaker
  • Dr Chan Tsun Leung

Dr Chan Tsun Leung

Laboratory Director, Phase Scientific Medical Laboratory, Hong Kong; Honorary Associate Professor, Department of Pathology, The University of Hong Kong; Honorary Associate Professor, Department of Surgery, The University of Hong Kong; Director of Hong Kong Hereditary Breast Cancer Family Registry

Enquiry
(kwkman@hkuspace.hku.hk)
Relevant Programmes
Higher Certificate in Medical Laboratory Science B.Sc.(Hons.) in Biological Science MSc in Biomedical Science Advanced Diploma in Bioscience Postgraduate Certificate in Bioinformatics for Medical Laboratory Technologists
moreRelevant Programmes

In this talk, Dr. Chris Chan will explore the shift from traditional diagnosis to precision medicine and the impact of new technologies in medical laboratories. Dr. Chan earned his Ph.D. in the Department of Pathology, Faculty of Medicine at The University of Hong Kong. Currently, he is the Laboratory Director of the Phase Scientific Medical Laboratory.

With almost 30 years of extensive clinical experience spanning both academic and hospital settings, Dr. Chan has demonstrated a strong commitment to integrating cutting-edge technologies into clinical practice. Some of the innovative techniques he has implemented include short-read next-generation sequencing (NGS), long-read NGS, and droplet digital PCR.

More recently, Dr. Chan has been exploring the broader application of urine-based clinical tests. This includes introducing the use of urine samples for HPV testing, which may offer comparable performance to the traditional Pap smear approach. Dr. Chan also believe that urine specimen can be used in the field of oncology.

These innovations aim to improve diagnostic capabilities in medical laboratories and advance the field of medical testing.

 

Language: English